HANNAH WOODARD: Open Payments
NPI 1063171247 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,084 in 39 payments from 14 companies in 2025. Trend: 2023 $1,278 · 2024 $791 · 2025 $1,084
Food & beverage: $1,084
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $212 |
| Novartis Pharmaceuticals Corporation | 10 | $197 |
| Actelion Pharmaceuticals US, Inc. | 6 | $176 |
| Medtronic, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 5 | $84 |
| PFIZER INC. | 4 | $80 |
| Merck Sharp & Dohme LLC | 3 | $68 |
| Edwards Lifesciences Corporation | 1 | $28 |
| CARDIVA MEDICAL, INC. | 1 | $22 |
| ABIOMED | 1 | $22 |
Products named: LEQVIO, General - Stents, COREVALVE EVOLUT R, OPSUMIT, General - Therapies, VERQUVO, VYNDAQEL, OPSYNVI.
Industry payments across GA — which companies pay providers there.
